Zwaan CM, Reinhardt K, Hollink IH, Klusmann JH, Lehrnbecher T, Roettgers S, Stary J, Dworzak M, Welte K, Creutzig U, Reinhardt D. J Clin Oncol. 2010 May 20;28(15):2591-7. doi: 10.1200/JCO.2009.25.9010 [...] severe congenital neutropenia. Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K. Haematologica. 2010 Jul;95(7):1207-10. doi: 10.3324/haematol.2009.017665. Epub 2010 Mar 10. PMID: [...] balance between leukemia and pancytopenia. Wicke DC, Meyer J, Buesche G, Heckl D, Kreipe H, Li Z, Welte KH, Ballmaier M, Baum C, Modlich U. Mol Ther. 2010 Feb;18(2):343-52. doi: 10.1038/mt.2009.233. Epub
. PMID: 34875087 Gerecke LKV, Schmidt JJ, Hafer C, Eden G, Bode-Böger SM, Martens-Lobenhoffer J, Welte T, Kielstein JT. Fosfomycin single- and multiple-dose pharmacokinetics in patients undergoing prolonged [...] 34586373 Schmidt JJ, Strunk AK, David S, Bode-Böger SM, Martens-Lobenhoffer J, Knitsch W, Scherneck S, Welte T, Kielstein JT. Single- and multiple-dose pharmacokinetics and total removal of colistin in critically [...] 1093/jac/dky511. PMID: 30624668 Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S. Clinical course, treatment and outcome of Pneumocystis pneumonia
Ingelheim Pharma GmbH & Co. KG TRISTARDS / ThRombolysIS Therapy for ARDS Project leader: Prof. Dr. Tobias Welte Department / Institute: Department of Pneumology A Phase IIb/III operationally seamless, open-label [...] otilimab IV in patients with severe pulmonary COVID-19 related disease Project leader: Prof. Dr. Tobias Welte Department / Institute: Department of Pneumology A randomized, double-blind, placebo-controlled, study [...] MULTICENTER STUDY OF IFX-1 IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA Project leader: Prof. Dr. Tobias Welte Department / Institute: Department of Pneumology A pragmatic adaptive randomized controlled Phase
Center Internal Medicine Medical Director of the Center for Internal Medicine: Prof. Dr. med. Tobias Welte Tel. +49 511 532 3530 Fax +49 511 532 3353 Managing Director of the Center of Internal Medicine: Prof
Medicine and Infectious Diseases following the untimely passing of our esteemed head, Prof. Dr. Tobias Welte. On the following pages, we would like to introduce our clinic to you. Here, you will find information
Info February 2015) MHH schult Jungforscher aus aller Welt; HBRS Anniversary (HAZ 23.10.10) New students 2008 (HAZ, 14.10.08) Kluge Köpfe aus aller Welt (HAZ, 16.10.07) MHH Experten wollen in Indien forschen
ObsTructive Lung Disease Hannover, BREATH for short, and will be coordinated by Prof. Dr. Tobias Welte (Clinic for Pneumology, MHH).
Prof. Dr. D. Hilfiker-Kleiner Prof. Dr. S. Petri Prof. Dr. M. Stiesch Prof. Dr. T. Thum Prof. Dr. T. Welte Prof. Dr. T. Thum was elected chairman of the Steering Committee. Elected members of the Steering
filtration of buffer, and freezing. Vasc Health Risk Manag. 2010 Dec 6;6:1125-33. Duesberg CB , Welte T, Pletz MW. The Lys137Asn mutation as surrogate marker for developing fluoroquinolone resistance [...] 2007;19(6):750-1; discussion 751-2. Duesberg CB , Malhotra-Kumar S, Goossens H, McGee L, Klugman KP, Welte T, Pletz MW. Interspecies recombination occurs frequently in quinolone resistance determining regions [...] Hahn I, Ding N, Srivastava M, Christman JW, Mack M, Reutershan J, Briles DE, Paton JC, Winter C, Welte T, Maus UA. Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage
Medizinischen Hochschule Hannover zu diesen am häufigsten zitierten Forscherinnen und Forschern der Welt zählen: Professor Dr. Michael Manns, MHH-Präsident und ehemaliger Direktor der MHH-Klinik für Gas